Nyxoah Announces Participation within the
Cantor 2021 Digital World Healthcare Convention
(Belgium), September 13, 2021, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Firm”), a medical expertise firm centered on the event and commercialization of revolutionary options to deal with Obstructive Sleep Apnea (OSA), as we speak introduced that Olivier Taelman, Chief Govt Officer, will take part on the Cantor 2021 World Healthcare Convention on Tuesday, September 28, 2021, with a digital presentation at 4:00 pm CET/10:00 am ET.
A dwell webcast and replay of this occasion will likely be accessible on the Firm’s buyers relations web site at https://buyers.nyxoah.com/
Nyxoah is a medical expertise firm centered on the event and commercialization of revolutionary options to deal with Obstructive Sleep Apnea (OSA). Nyxoah’s lead answer is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation remedy for OSA, the world’s commonest sleep disordered respiration situation that’s related to elevated mortality danger and cardiovascular comorbidities. Nyxoah is pushed by the imaginative and prescient that OSA sufferers ought to get pleasure from restful nights and really feel enabled to dwell their life to its fullest.
Following the profitable completion of the BLAST OSA examine, the Genio® system obtained its European CE Mark in 2019. Nyxoah accomplished two profitable IPOs: on Euronext in September 2020 and NASDAQ in July 2021. Following the optimistic outcomes of the BETTER SLEEP examine, Nyxoah is looking for for the growth of its therapeutic indications to Full Concentric Collapse (CCC) sufferers, at present contraindicated in rivals’ remedy. Moreover, the Firm is at present conducting the DREAM IDE pivotal examine for FDA and US commercialization approval.
Fabian Suarez, Chief Monetary Officer
+32 10 22 24 55
- ENGLISH – NYXH Publicizes Cantor HC – FINAL